May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Optic Neuropathy Secondary to Linezolid for Vancomycin Resistant Infections
Author Affiliations & Notes
  • J.G. McHenry
    Ophthalmology, Univ TX–Southwestern, Addison, TX
  • Footnotes
    Commercial Relationships  J.G. McHenry, None.
  • Footnotes
    Support  RPB
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 665. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.G. McHenry; Optic Neuropathy Secondary to Linezolid for Vancomycin Resistant Infections . Invest. Ophthalmol. Vis. Sci. 2005;46(13):665.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To describe a case of severe bilateral optic neuropathy in a patient treated with Linezolid. Methods: We reviewed the records of a 62 year old female with a vancomycin resistant Staphylococcus osteomyelitis treated with Linezolid who developed sudden visual loss to hand motion in each eye. Results: The patient was treated with prednisone and improved in two months to 20/80 in the right and counting fingers in the left. Conclusions: One of the few treatments for vancomycin resistant Staphylococcus aureus is Linezolid. With these infections increasing, it is important to be aware of new causes of optic neuropathy.

Keywords: neuro-ophthalmology: optic nerve • drug toxicity/drug effects • optic disc 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.